Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus
Identifieur interne : 001631 ( Ncbi/Curation ); précédent : 001630; suivant : 001632Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus
Auteurs : Timothy M. Uyeki ; Karl J. Erlandson ; George Korch ; Michael O Ara ; Michael Wathen ; Jean Hu-Primmer ; Sally Hojvat ; Erik J. Stemmy ; Armen DonabedianSource :
- Emerging Infectious Diseases [ 1080-6040 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Vaccins antiviraux.
- médecine vétérinaire : Infections à coronavirus.
- virologie : Infections à coronavirus.
- Animaux, Chameaux, Coronavirus du syndrome respiratoire du Moyen-Orient, Humains, Infections à coronavirus, Modèles animaux de maladie humaine.
English descriptors
- KwdEn :
- MESH :
- chemical , immunology : Viral Vaccines.
- prevention & control : Coronavirus Infections.
- veterinary : Coronavirus Infections.
- virology : Coronavirus Infections.
- Animals, Camelus, Disease Models, Animal, Humans, Middle East Respiratory Syndrome Coronavirus.
Abstract
Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.
Url:
DOI: 10.3201/eid2207.160022
PubMed: 27191188
PubMed Central: 4918159
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000074
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000074
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000C00
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001114
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001114
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001149
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001631
Links to Exploration step
PMC:4918159Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus</title>
<author><name sortKey="Uyeki, Timothy M" sort="Uyeki, Timothy M" uniqKey="Uyeki T" first="Timothy M." last="Uyeki">Timothy M. Uyeki</name>
</author>
<author><name sortKey="Erlandson, Karl J" sort="Erlandson, Karl J" uniqKey="Erlandson K" first="Karl J." last="Erlandson">Karl J. Erlandson</name>
</author>
<author><name sortKey="Korch, George" sort="Korch, George" uniqKey="Korch G" first="George" last="Korch">George Korch</name>
</author>
<author><name sortKey="O Ara, Michael" sort="O Ara, Michael" uniqKey="O Ara M" first="Michael" last="O Ara">Michael O Ara</name>
</author>
<author><name sortKey="Wathen, Michael" sort="Wathen, Michael" uniqKey="Wathen M" first="Michael" last="Wathen">Michael Wathen</name>
</author>
<author><name sortKey="Hu Primmer, Jean" sort="Hu Primmer, Jean" uniqKey="Hu Primmer J" first="Jean" last="Hu-Primmer">Jean Hu-Primmer</name>
</author>
<author><name sortKey="Hojvat, Sally" sort="Hojvat, Sally" uniqKey="Hojvat S" first="Sally" last="Hojvat">Sally Hojvat</name>
</author>
<author><name sortKey="Stemmy, Erik J" sort="Stemmy, Erik J" uniqKey="Stemmy E" first="Erik J." last="Stemmy">Erik J. Stemmy</name>
</author>
<author><name sortKey="Donabedian, Armen" sort="Donabedian, Armen" uniqKey="Donabedian A" first="Armen" last="Donabedian">Armen Donabedian</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">27191188</idno>
<idno type="pmc">4918159</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918159</idno>
<idno type="RBID">PMC:4918159</idno>
<idno type="doi">10.3201/eid2207.160022</idno>
<date when="2016">2016</date>
<idno type="wicri:Area/Pmc/Corpus">000074</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000074</idno>
<idno type="wicri:Area/Pmc/Curation">000074</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000074</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000C00</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000C00</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:27191188</idno>
<idno type="wicri:Area/PubMed/Corpus">001114</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001114</idno>
<idno type="wicri:Area/PubMed/Curation">001114</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001114</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001149</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001149</idno>
<idno type="wicri:Area/Ncbi/Merge">001631</idno>
<idno type="wicri:Area/Ncbi/Curation">001631</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus</title>
<author><name sortKey="Uyeki, Timothy M" sort="Uyeki, Timothy M" uniqKey="Uyeki T" first="Timothy M." last="Uyeki">Timothy M. Uyeki</name>
</author>
<author><name sortKey="Erlandson, Karl J" sort="Erlandson, Karl J" uniqKey="Erlandson K" first="Karl J." last="Erlandson">Karl J. Erlandson</name>
</author>
<author><name sortKey="Korch, George" sort="Korch, George" uniqKey="Korch G" first="George" last="Korch">George Korch</name>
</author>
<author><name sortKey="O Ara, Michael" sort="O Ara, Michael" uniqKey="O Ara M" first="Michael" last="O Ara">Michael O Ara</name>
</author>
<author><name sortKey="Wathen, Michael" sort="Wathen, Michael" uniqKey="Wathen M" first="Michael" last="Wathen">Michael Wathen</name>
</author>
<author><name sortKey="Hu Primmer, Jean" sort="Hu Primmer, Jean" uniqKey="Hu Primmer J" first="Jean" last="Hu-Primmer">Jean Hu-Primmer</name>
</author>
<author><name sortKey="Hojvat, Sally" sort="Hojvat, Sally" uniqKey="Hojvat S" first="Sally" last="Hojvat">Sally Hojvat</name>
</author>
<author><name sortKey="Stemmy, Erik J" sort="Stemmy, Erik J" uniqKey="Stemmy E" first="Erik J." last="Stemmy">Erik J. Stemmy</name>
</author>
<author><name sortKey="Donabedian, Armen" sort="Donabedian, Armen" uniqKey="Donabedian A" first="Armen" last="Donabedian">Armen Donabedian</name>
</author>
</analytic>
<series><title level="j">Emerging Infectious Diseases</title>
<idno type="ISSN">1080-6040</idno>
<idno type="eISSN">1080-6059</idno>
<imprint><date when="2016">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Camelus</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Coronavirus Infections (veterinary)</term>
<term>Coronavirus Infections (virology)</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
<term>Viral Vaccines (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Chameaux</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Humains</term>
<term>Infections à coronavirus ()</term>
<term>Infections à coronavirus (médecine vétérinaire)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Modèles animaux de maladie humaine</term>
<term>Vaccins antiviraux (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="médecine vétérinaire" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="veterinary" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Camelus</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Chameaux</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Modèles animaux de maladie humaine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001631 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001631 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:4918159 |texte= Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:27191188" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
This area was generated with Dilib version V0.6.33. |